An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder
Clinical trial NCT02226458 · WITHDRAWN
Trial details
- NCT number
- NCT02226458
- Sponsor
- Edison Pharmaceuticals Inc
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-31
- Primary completion
- 2015-11-30
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.